Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
- Primary Objective will be to evaluate the use of Ga-67 citrate as an alternative
radiopharmaceutical for CSF imaging.
- Secondary Objective will be to evaluate the biodistribution, pharmacokinetics and
radiation dosimetry of In 111 DTPA and gallium-67 after intrathecal injection during
remission of leptomeningeal metastasis (LM) and during LM occurrence, remission and
recurrence.